Study of why blood clots in veins come back
Part of Blood & lymphatic clinical trials.
This study follows people who have had a vein blood clot (or related venous clot) to understand what factors may make the clot happen again. It may help clinicians find better ways to prevent repeat clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older, or be a minor with parent consent
- Have a current or recent blood clot problem in a vein (venous thromboembolic disease)
- Be able to understand and communicate enough to take part in study discussions
- If you have cancer, the study may include you at any age
- Be covered by social security and be willing to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have both cancer and a blood clot. It aims to learn more about how these clots happen and how they are treated in cancer patients, so doctors can improve care.
This study helps you and your doctor decide together whether to continue blood thinners after a first unexpected blood clot. You join after 3 to 6 months of treatment to discuss your options.
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
This study follows patients who have had a blood clot in their leg or lung to learn more about their health over time. It helps doctors understand how to better care for people with blood clots.
This trial aims to learn more about blood clots, inflammation, and blood vessel problems. It may help researchers better understand these conditions and how they affect people.
This is a “registry” study that collects information about people who have a confirmed blood clot in a vein, lung, or a superficial vein. It may help doctors understand outcomes over time, especially what happens in the first few months after diagnosis.
Hear when a new Thromboembolic Venous Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.